CorMedix, Inc. (CRMD)
10.78
+0.22
(+2.08%)
USD |
NASDAQ |
Dec 08, 11:13
CorMedix Shareholders Equity (Quarterly): 374.13M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Pfizer Inc. | 92.80B |
| ANI Pharmaceuticals, Inc. | 505.82M |
| Arcutis Biotherapeutics, Inc. | 158.07M |
| Alkermes Plc | 1.733B |
| Talphera, Inc. | 19.18M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 750.86M |
| Total Liabilities (Quarterly) | 376.73M |
| Debt to Equity Ratio | 0.0117 |
| Current Ratio | 1.942 |
| Net Debt Paydown Yield | -0.08% |